Michael Shultz

Michael Shultz

Company: ViewPoint Therapeutics

Job title: Co-founder & Chief Scientific Officer,


Pb-203 Image-Guided Pb-212 Alpha Particle Therapy for Cancer – Preclinical Evidence of a Potent Paradigm 11:30 am

Exploring the rationale behind exploring behind selecting newer isotopes Considering side effects and efficacy: which combinations can complement these novel isotopes to address these challengesRead more

day: Day One Track A AM

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.